Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Long-Term Investments (2016)

Niagen Bioscience (NAGE) has disclosed Long-Term Investments for 2 consecutive years, with $20318.0 as the latest value for Q4 2016.

  • Quarterly Long-Term Investments changed N/A to $20318.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $20318.0 through Dec 2016, changed N/A year-over-year, with the annual reading at $20318.0 for FY2016, N/A changed from the prior year.
  • Long-Term Investments for Q4 2016 was $20318.0 at Niagen Bioscience, roughly flat from $20318.0 in the prior quarter.
  • The five-year high for Long-Term Investments was $2.7 million in Q1 2013, with the low at $20318.0 in Q4 2016.